Skip to main navigation Skip to search Skip to main content

Immunogenicity and Safety of Meningococcal (Serogroups A, C, Y and W-135) Polvsaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra) in Children Aged 4 to 6 Years in the US when Administered Concomitantly with a Fifth Dose Diphtheria and

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date08/18/06 → 08/31/10

Funding

  • Sanofi Pasteur Incorporated: $73,780.00